The Patient Confusion Crisis
Pharma faces a $5B crisis as 35-40% of patients abandon specialty prescriptions. Misinformation from social media is eroding treatment adherence.
- Publisher
- Hoot Health, Inc.
- Length
- 13 pages
- File
- 220 KB PDF
Quick answer
The Patient Confusion Crisis is a 13-page whitepaper from Hoot Health, Inc. covering GLOBAL pharma intelligence. Pharma faces a $5B crisis as 35-40% of patients abandon specialty prescriptions. Misinformation from social media is eroding treatment adherence.
Why this matters
Pharma faces a $5B crisis as 35-40% of patients abandon specialty prescriptions. Misinformation from social media is eroding treatment adherence.
Executive summary
- Pharma faces a $5B crisis as 35-40% of patients abandon specialty prescriptions. Misinformation from social media is eroding treatment adherence.
Market Impact
| Regulatory | high |
|---|---|
| Commercial | high |
| Competitive | medium |
| Investment | high |
Who should read this
- Regulatory professionals
- Clinical operations
- BD & strategy teams
Ask about this report
AI-assisted answers grounded in NovaPharmaNews intelligence
Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.
Download the full 13-page PDF
Free · 220 KB · Instant access after email
This white paper presents a data-driven analysis of the patient confusion crisis affecting treatment initiation and adherence in complex therapies.
- 35-40% of patients abandon specialty prescriptions before the first fill.
- 50% of patients who start therapy discontinue within 12 months.
- Only 3% of patients utilize existing $5 billion patient support programs.
- 92% of patients trust their prescribing physician over other information sources.
- Proposes physician-led video education via SMS to improve patient engagement and adherence.
Frequently asked questions
What whitepapers does NovaPharmaNews publish?
Our research library curates FDA, EMA, and industry publisher PDFs — regulatory guidance, clinical analyses, manufacturing reports, and market intelligence. Each report includes an AI-summarized landing page with key takeaways and a gated PDF download.
How do I download a whitepaper?
Open any report page, scroll to the download form, and enter your work email. You receive instant PDF access and can opt in to weekly pharma intelligence updates. Downloads are free for healthcare professionals.
How do whitepapers connect to news and pipeline data?
Report pages link to related intelligence — company profiles, drug INN pages, clinical trials, pipeline programs, and topic hubs. Use the intelligence spokes on each page to explore the entity graph behind the research.
Ready to read the full report?
Join 12,000+ pharma leaders getting deep industry analysis delivered weekly.
Related topic hubs
Editorial coverage and intelligence directories for this report's beat.
Explore the intelligence platform
Related intelligence
Strategies to Enhance Recruitment of Female Participants to Cardiovascular Research
This consensus document outlines strategies to increase female representation in cardiovascular clinical trials, addressing significant unde…
British Society of Gastroenterology Guidelines on Inflammatory Bowel Disease in Adults: 2025
The updated BSG guidelines emphasize the necessity of ileocolonoscopy for IBD diagnosis and advocate for immunomodulators in all patients.
🔒 From Automotive to MedTech: Proven Software Development Practices
This whitepaper outlines how MedTech can leverage automotive software development practices to enhance compliance and accelerate innovation …